RCT supports the use of therapeutic heparin in moderately ill patients admitted to the hospital with Covid-19.
17 Oct, 2021 | 21:35h | UTCRelated studies (some conflicting results)
Commentary on Twitter
What are the effects of therapeutic heparin compared with prophylactic heparin among moderately ill patients with covid-19 admitted to hospital? #BMJResearch by @sholzberg and colleagues.
Includes a #VisualAbstract summarising the study #BMJInfographichttps://t.co/82VisuBKSU pic.twitter.com/b06TdIJvLX
— The BMJ (@bmj_latest) October 15, 2021